Detailed Information on Publication Record
2003
Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action
KAŠPÁRKOVÁ, Jana, Olga NOVAKOVÁ, María Victoria MARINI PALOMEQUE, Yousef NAJAJREH, Dan GIBSON et. al.Basic information
Original name
Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action
Name in Czech
Aktivace trans geometrie bifunkcnich mononuklearnich platinovych komplexu piperidinovym ligandem.
Authors
KAŠPÁRKOVÁ, Jana (203 Czech Republic), Olga NOVAKOVÁ (203 Czech Republic), María Victoria MARINI PALOMEQUE (858 Uruguay), Yousef NAJAJREH (275 Palestine, State of), Dan GIBSON (376 Israel), Jose-Manuel PEREZ (724 Spain) and Viktor BRABEC (203 Czech Republic, guarantor)
Edition
Journal of Biological Chemistry, Bethesda, USA, Amer. Soc. Biochem. Mol. Biol. 2003, 0021-9258
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10610 Biophysics
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 6.482
RIV identification code
RIV/00216224:14310/03:00029122
Organization unit
Faculty of Science
Keywords in English
cisplatin; platinum complexes; DNA; antitumor
Tags
Změněno: 15/11/2008 17:39, Mgr. María Victoria Marini Palomeque, Ph.D.
V originále
A paradigm for the structure-pharmacological activity relationship of bifunctional platinum antitumor drugs is that the trans isomer of antitumor cisplatin (transplatin) is clinically ineffective. To this end, however, several new complexes of the trans structure have been identified that exhibit cytotoxicity in tumor cells that is even better than that of the analogous cis isomers. We reported recently (Kasparkova, J., Marini, V., Najajreh, Y., Gibson, D., and Brabec, V. (2003) Biochemistry 42, 6321-6332) that the replacement of one ammine ligand by the heterocyclic ligand, such as piperidine, piperazine, or 4-picoline in the molecule of transplatin resulted in a radical enhancement of its cytotoxicity. We examined oligodeoxyribonucleotide duplexes bearing a site-specific cross-link of the transplatin analogue containing the piperidine ligand by biochemical methods. The results indicate that in contrast to transplatin, trans-(PtCl2(NH3)(piperidine)) forms stable 1,3-intrastrand cross-links in double-helical DNA that distort DNA and are not readily removed from DNA by nucleotide excision repair system. Hence, the intrastrand cross-links of trans-(PtCl2(NH3)(piperidine)) could persist for a sufficiently long time, potentiating its toxicity toward tumor cells. trans-(PtCl2(NH3)(piperidine)) also forms in DNA minor interstrand cross-links that are similar to those of transplatin so that these adducts appear less likely candidates for genotoxic lesion responsible for antitumor effects of trans-(PtCl2(NH3)(piperidine)). Hence, the role of structurally unique intrastrand cross-links in the anti-tumor effects of transplatin analogues in which one ammine group is replaced by a heterocyclic ligand may predominate.
In Czech
cz
Links
GA305/02/1552, research and development project |
|